MedPath

Clinical Study on Anti-Dandruff Herbal Shampoo

Phase 2
Completed
Conditions
Health Condition 1: L219- Seborrheic dermatitis, unspecified
Registration Number
CTRI/2022/12/048288
Lead Sponsor
Believe Pte. Ltd.,
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
20
Inclusion Criteria

• Healthy Indian male/female volunteer aged between 18-45 years (both inclusive)

• Willing to give Informed Consent

• Subjects diagnosed with of mild to moderate dandruff, assessed by mean total Adherent Scalp Flaking Score (ASFS) of 8 zones in the scalp.

•Willing to complete the study assessments/questionnaires.

• Willing to avoid usage of his/her own hair care products in controlling hair fall and dandruff for at least one week before the commencement and during this study.

Exclusion Criteria

• Pregnancy or breast feeding.

• Patients diagnosed with severe dandruff, Itching, flaking, pruritis and visible inflammation over face, retro auricular area, and the upper chest.

• Patients with inflammatory or infective scalp conditions.

•Patients with history of hypersensitivity to hair products

• Patients with mild to severe anaphylaxis reaction.

• Patients with pre existing severe systemic disease necessitating long term medication.

• Evidence of significant uncontrolled co morbid disease which in the investigators opinion would jeopardize patient participation.

• History of cancer, including solid tumors, hematologic malignancies and carcinoma in situ.

• Participation in the current or previous clinical trial with any approved or investigational products during the past 1 month.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
â?¢Reduction of dandruff through Adherent Scalp Flaking Score (ASFS) from baseline to end of the study.Timepoint: Day 0 to Day 30
Secondary Outcome Measures
NameTimeMethod
â?¢Consumer feedback will be obtained via a set of subjective questionnaires to evaluate the response towards the product.Timepoint: Day 0 to Day 30
© Copyright 2025. All Rights Reserved by MedPath